Evidence map›Paper›PMID 24733560›Full record

ReviewReviews in medical virology2014

Immune escape of γ-herpesviruses from adaptive immunity.

Zhuting Hu, Edward J Usherwood

Abstract readReview
In one paragraph

Review in Reviews in medical virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Host-virus interaction and viral evasion.Cell biology international · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Regulatory T Cell Effect on CD8AIDS research and human retroviruses · 2017
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhuting HuDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Edward J Usherwood
Dartmouth College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
T cell function in murine gammaherpesvirus infectionR01AI069943 · NIAID · DARTMOUTH COLLEGE · PI USHERWOOD, EDWARD J · 2007 to 2016
$3.3M
Immune surveillance in murine gammaherpesvirus infectionR01CA103642 · NCI · DARTMOUTH COLLEGE · PI USHERWOOD, EDWARD J · 2004 to 2013
$3.1M
T cell function in murine gammaherpesvirus infectionR56AI069943 · NIAID · DARTMOUTH COLLEGE · PI USHERWOOD, EDWARD J · 2012 to 2012
$403k
NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA103642NCI NIH HHS R01CA103642NIAID NIH HHS R01 AI069943NIAID NIH HHS R01AI069943NIAID NIH HHS R56 AI069943
6 · The paper itself

Abstract

Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are two γ-herpesviruses identified in humans and are strongly associated with the development of malignancies. Murine γ-herpesvirus (MHV-68) is a naturally occurring rodent pathogen, representing a unique experimental model for dissecting γ-herpesvirus infection and the immune response. These γ-herpesviruses actively antagonize the innate and adaptive antiviral responses, thereby efficiently establishing latent or persistent infections and even promoting development of malignancies. In this review, we summarize immune evasion strategies of γ-herpesviruses. These include suppression of MHC-I-restricted and MHC-II-restricted antigen presentation, impairment of dendritic cell functions, downregulation of costimulatory molecules, activation of virus-specific regulatory T cells, and induction of inhibitory cytokines. There is a focus on how both γ-herpesvirus-derived and host-derived immunomodulators interfere with adaptive antiviral immunity. Understanding immune-evasive mechanisms is essential for developing future immunotherapies against EBV-driven and KSHV-driven tumors.

Indexed as

Immune EvasionAdaptive ImmunityAnimalsGammaherpesvirinaeHerpesviridae InfectionsHumans

Identifiers

PMID24733560
PMCPMC4198523
OpenAlexW2144767711

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.